MGC BioPQQ Sustainability Profile
MGC BioPQQ, a subsidiary of the MGC Group, is a leading player in the biotechnology industry, headquartered in Japan. Established in 2015, the company has rapidly gained recognition for its innovative approach to health and wellness, particularly in the development of bioactive compounds. Specialising in the production of Pyrroloquinoline Quinone (PQQ), MGC BioPQQ offers unique products that support cellular energy and overall vitality. Their commitment to quality and scientific research has positioned them as a trusted name in the market, catering to both domestic and international clients. With a focus on sustainability and cutting-edge technology, MGC BioPQQ continues to make significant strides in the health supplement sector, contributing to advancements in nutritional science and enhancing consumer well-being.
DitchCarbon Score
How does MGC BioPQQ's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
MGC BioPQQ's score of 34 is higher than 58% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
MGC BioPQQ's reported carbon emissions
In 2023, MGC BioPQQ reported total carbon emissions of approximately 10,000,000 kg CO2e, with emissions distributed across various scopes: 715,000,000 kg CO2e (Scope 1), 682,000,000 kg CO2e (Scope 2), and 9,265,000,000 kg CO2e (Scope 3). The total emissions from Scope 1 and 2 combined amounted to about 1,396,000,000 kg CO2e. The company has set ambitious long-term climate commitments, aiming for a zero-carbon society by 2050. This commitment encompasses both Scope 1 and Scope 2 emissions, with initiatives to promote energy transition starting in 2023. MGC BioPQQ's emissions data is not cascaded from a parent company, ensuring that the reported figures reflect its direct operations. The company is actively working towards reducing its carbon footprint while aligning with industry standards for climate action.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|
| Scope 1 | 749,010,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 222,812,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | 7,134,439,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 00,000,000,000 | 0,000,000,000 | 0,000,000,000 |
How Carbon Intensive is MGC BioPQQ's Industry?
How Carbon Intensive is MGC BioPQQ's Location?
MGC BioPQQ's Scope 3 Categories Breakdown
MGC BioPQQ's Scope 3 emissions, which decreased by 1% last year and increased by approximately 30% since 2016, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 57% of Scope 3 emissions.
Top Scope 3 Categories
MGC BioPQQ's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
MGC BioPQQ has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
